Oncoprotein Bmi-1 renders apoptotic resistance to glioma cells through activation of the IKK-nuclear factor-kappaB Pathway.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  American Journal of Pathology

• Publication date

  2010-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2353/ajpath.2010.090502PMID 20035051PMCID PMC2808077
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Copy number alterations of the polycomb gene BMI1 in gliomas

  2008cited by this paper
• Expression of Bmi-1 in epidermis enhances cell survival by altering cell cycle regulatory protein expression and inhibiting apoptosis.

  2008cited by this paper
• Bmi‐1 expression predicts prognosis for patients with gastric carcinoma

  2008cited by this paper
• Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal.

  2008cited by this paper
• NF-kappaB and cancer-identifying targets and mechanisms.

  2008cited by this paper
• Astrocyte Elevated Gene-1 is a Novel Prognostic Marker for Breast Cancer Progression and Overall Patient Survival

  2008cited by this paper
• Malignant gliomas in adults.

  2008cited by this paper
• Increased polycomb-group oncogene Bmi-1 expression correlates with poor prognosis in hepatocellular carcinoma

  2008cited by this paper
• Malignant astrocytic glioma: genetics, biology, and paths to treatment.

  2007cited by this paper
• Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma.

  2007cited by this paper
• Molecular targets of glioma invasion

  2007cited by this paper
• Expression changes in EZH2, but not in BMI-1, SIRT1, DNMT1 or DNMT3B are associated with DNA methylation changes in prostate cancer

  2007cited by this paper
• ELMO1 and Dock180, a bipartite Rac1 guanine nucleotide exchange factor, promote human glioma cell invasion.

  2007cited by this paper
• Bmi-1 cooperates with H-Ras to transform human mammary epithelial cells via dysregulation of multiple growth-regulatory pathways.

  2007cited by this paper
• Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells.

  2006cited by this paper
• Deregulated expression of Polycomb-group oncogenes in human malignant lymphomas and epithelial tumors.

  2005cited by this paper
• Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis.

  2005cited by this paper
• Ink4a and Arf differentially affect cell proliferation and neural stem cell self-renewal in Bmi1-deficient mice.

  2005cited by this paper
• Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways.

  2005cited by this paper
• Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer.

  2005cited by this paper
• Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway.

  2004cited by this paper
• Inhibitory action of novel aromatic diamine compound on lipopolysaccharide‐induced nuclear translocation of NF‐κB without affecting IκB degradation

  2004cited by this paper
• Inhibitory action of novel aromatic diamine compound on lipopolysaccharide-induced nuclear translocation of NF-kappaB without affecting IkappaB degradation.

  2004cited by this paper
• Wedelolactone suppresses LPS-induced caspase-11 expression by directly inhibiting the IKK Complex

  2004cited by this paper
• Apoptosis-targeted therapies for cancer.

  2003cited by this paper
• Aberrant nuclear factor-kappaB activity and its participation in the growth of human malignant astrocytoma.

  2002cited by this paper
• NF-κB in cancer: from innocent bystander to major culprit

  2002cited by this paper
• NF-kappaB in cancer: from innocent bystander to major culprit.

  2002cited by this paper
• Polycomb repression: from cellular memory to cellular proliferation and cancer.

  2002cited by this paper
• Pathology and genetics of tumours of the nervous system.

  2000cited by this paper
• Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF.

  1999cited by this paper
• Frequent Co‐Alterations of TP53, p16/CDKN2A, p14ARF, PTEN Tumor Suppressor Genes in Human Glioma Cell Lines.

  1999cited by this paper
• Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase.

  1999cited by this paper
• Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in E mu-myc transgenic mice.

  1991cited by this paper
• Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging.

  1991cited by this paper
• Tumorigenesis and Neoplastic Progression Bmi-1 Is Essential for the Tumorigenicity of Neuroblastoma Cells

  year unknowncited by this paper
• Review Stem Cells and Cancer: The Polycomb Connection

  year unknowncited by this paper

• Insights Into the Role of Bmi‐1 Deregulation in Promoting Stemness and Therapy Resistance in Glioblastoma: A Narrative Review

  2025cites this paper
• The significance of epithelial–mesenchymal transition (EMT) in the initiation, plasticity, and treatment of glioblastoma

  2025cites this paper
• MiR-128-3p – a gray eminence of the human central nervous system

  2024cites this paper
• Targeting Cancer Stem Cells through Epigenetic Modulation of Interferon Response

  2022cites this paper
• The role of NF-κB in myocardial ischemia/reperfusion injury.

  2022cites this paper
• The Crucial Roles of Bmi-1 in Cancer: Implications in Pathogenesis, Metastasis, Drug Resistance, and Targeted Therapies

  2022cites this paper
• An Intelligent Nanoplatform for Orthotopic Glioblastoma Therapy by Nonferrous Ferroptosis

  2022cites this paper
• Human cutaneous interfollicular melanocytes differentiate temporarily under genotoxic stress

  2022cites this paper
• Nanomedicines Targeting Glioma Stem Cells.

  2022cites this paper
• Nitidine chloride suppresses epithelial‐mesenchymal transition and stem cell‐like properties in glioblastoma by regulating JAK2/STAT3 signaling

  2021cites this paper
• Piperazine-Derived α1D/1A Antagonist 1- Benzyl-N- (3-(4- (2-Methoxyphenyl) Piperazine-1-yl) Propyl) -1H- Indole-2- Carboxamide Induces Apoptosis in Benign Prostatic Hyperplasia Independently of α1-Adrenoceptor Blocking

  2021cites this paper
• Association of High Expression of Mitochondrial Fission Regulator 2 with Poor Survival of Patients with Esophageal Squamous Cell Carcinoma

  2021cites this paper
• Family with sequence similarity 46 member a confers chemo-resistance to ovarian carcinoma via TGF-β/Smad2 signaling

  2021cites this paper
• Long noncoding RNA DANCR knockdown inhibits proliferation, migration and invasion of glioma by regulating miR-135a-5p/BMI1

  2020cites this paper
• ALKBH2 inhibition alleviates malignancy in colorectal cancer by regulating BMI1-mediated activation of NF-κB pathway

  2020cites this paper
• Long noncoding RNA LINC00673-v4 promotes aggressiveness of lung adenocarcinoma via activating WNT/β-catenin signaling

  2019cites this paper
• Acyl-CoA dehydrogenase long chain expression is associated with esophageal squamous cell carcinoma progression and poor prognosis

  2018cites this paper
• Cytotoxicity of ultraviolet-C radiation on a heterogeneous population of human glioblastoma multiforme cells: Meta-analysis.

  2018cites this paper
• Long Non-Coding RNA LINC01260 Inhibits the Proliferation, Migration and Invasion of Spinal Cord Glioma Cells by Targeting CARD11 Via the NF-κB Signaling Pathway

  2018cites this paper
• Transcription factor AP-4 promotes tumorigenic capability and activates the Wnt/β-catenin pathway in hepatocellular carcinoma

  2018cites this paper
• MicroRNA-374 a activates Wnt / b-catenin signaling to promote breast cancer metastasis

  2018cites this paper
• Up-regulated MiR-27-3p promotes the G1-S phase transition by targeting inhibitor of growth family member 5 in osteosarcoma.

  2018cites this paper
• Long Intergenic Noncoding RNA 00152 Promotes Glioma Cell Proliferation and Invasion by Interacting with MiR-16

  2018cites this paper
• The mechanism of BMI1 in regulating cancer stemness maintenance, metastasis, chemo- and radiation resistance

  2018cites this paper
• Gene Therapy, and Immunotherapy in Malignant Gliomas

  2018cites this paper
• Bmi-1 overexpression as an efficient prognostic marker in patients with nonsmall cell lung cancer

  2017cites this paper
• BMI-1 interacts with sMEK1 and inactivates sMEK1-induced apoptotic cell death.

  2017cites this paper
• Centrosomal protein 55 activates NF-κB signalling and promotes pancreatic cancer cells aggressiveness

  2017cites this paper
• Bmi-1-targeting suppresses osteosarcoma aggressiveness through the NF-κB signaling pathway

  2017cites this paper
• miR-500a-3p promotes cancer stem cells properties via STAT3 pathway in human hepatocellular carcinoma

  2017cites this paper
• Toxicarioside N induces apoptosis of human gastric cancer BGC-823 cells through NF-kB-mediated activation of Fas/FasL pathway

  2017cites this paper
• miR-217 targeting DKK1 promotes cancer stem cell properties via activation of the Wnt signaling pathway in hepatocellular carcinoma.

  2017cites this paper
• Effects of Ultraviolet Radiation on Glioma: Systematic Review

  2017cites this paper
• Bispecific antibody suppresses osteosarcoma aggressiveness through regulation of NF-κB signaling pathway

  2017cites this paper
• Significance of NF‐κB activation in immortalization of nasopharyngeal epithelial cells

  2016cites this paper
• Mel-18 negatively regulates stem cell-like properties through downregulation of miR-21 in gastric cancer

  2016cites this paper
• Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implication

  2016cites this paper
• Gankyrin sustains PI3K/GSK-3β/β-catenin signal activation and promotes colorectal cancer aggressiveness and progression

  2016cites this paper
• Bmi1 inhibition enhances the sensitivity of pancreatic cancer cells to gemcitabine

  2016influential citation
• N-cadherin promotes epithelial-mesenchymal transition and cancer stem cell-like traits via ErbB signaling in prostate cancer cells.

  2016cites this paper
• Bmi-1 regulates stem cell-like properties of gastric cancer cells via modulating miRNAs

  2016cites this paper
• Overexpression of Suprabasin is Associated with Proliferation and Tumorigenicity of Esophageal Squamous Cell Carcinoma

  2016cites this paper
• TWIST1 and BMI1 in Cancer Metastasis and Chemoresistance

  2016cites this paper
• Serine‐arginine protein kinase 1 promotes a cancer stem cell‐like phenotype through activation of Wnt/β‐catenin signalling in NSCLC

  2016cites this paper
• Silencing of Bmi-1 Gene Enhances Chemotherapy Sensitivity in Human Glioblastoma Cells

  2015cites this paper
• miR-340 suppresses glioblastoma multiforme

  2015cites this paper
• Epithelial–mesenchymal transition‐related factors in solid tumor and hematological malignancy

  2015cites this paper
• IDH1R132H decreases the proliferation of U87 glioma cells through upregulation of microRNA-128a

  2015cites this paper
• miR-302b suppresses cell invasion and metastasis by directly targeting AKT2 in human hepatocellular carcinoma cells

  2015cites this paper
• Expression Analysis of Genes Involved in the RB/E2F Pathway in Astrocytic Tumors

  2015cites this paper
• Overexpression and lack of copy number variation in the BMI-1 gene in human glioma.

  2015cites this paper
• Polycomb Group (PcG) Proteins and Human Cancers: Multifaceted Functions and Therapeutic Implications

  2015cites this paper
• Bmi‐1 regulates the migration and invasion of glioma cells through p16

  2015cites this paper
• Bmi1 Drives Stem-Like Properties and is Associated with Migration, Invasion, and Poor Prognosis in Tongue Squamous Cell Carcinoma

  2015cites this paper
• BMI Transcription Factor as a Novel Target for the Treatment of Brain Tumors

  2015cites this paper
• URGCP/URG4 promotes apoptotic resistance in bladder cancer cells by activating NF-κB signaling

  2015cites this paper
• Nuclear-encoded cytochrome c oxidase subunit 4 regulates BMI1 expression and determines proliferative capacity of high-grade gliomas

  2015cites this paper
• Radiosensitization of Primary Human Glioblastoma Stem-like Cells with Low-Dose AKT Inhibition

  2015cites this paper
• Anti-Angiogenesis, Gene Therapy, and Immunotherapy in Malignant Gliomas

  2014cites this paper
• LEF1 regulates glioblastoma cell proliferation, migration, invasion, and cancer stem-like cell self-renewal

  2014cites this paper
• A novel NF-κB/MMP-3 signal pathway involves in the aggressivity of glioma promoted by Bmi-1

  2014cites this paper
• Bmi-1 induces radioresistance by suppressing senescence in human U87 glioma cells

  2014cites this paper
• Application of the Chick Embryo Chorioallantoic Membrane in Neurosurgery Disease

  2014cites this paper
• Silencing BMI1 eliminates tumor formation of pediatric glioma CD133+ cells not by affecting known targets but by down-regulating a novel set of core genes

  2014cites this paper
• The emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma stemness.

  2014cites this paper
• Bmi1 regulates self-renewal and epithelial to mesenchymal transition in breast cancer cells through Nanog

  2014cites this paper
• Serine–arginine protein kinase 1 is associated with breast cancer progression and poor patient survival

  2014cites this paper
• MicroRNA-16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor-κB1/MMP9 signaling pathway

  2014cites this paper
• Ovarian Cancer Stem Cells: A New Target for Cancer Therapy

  2013cites this paper
• Deciphering the Mechanisms of Tumorigenesis in Human Pancreatic Ductal Epithelial Cells

  2013cites this paper
• Polycomb group proteins and MYC: the cancer connection

  2013cites this paper
• Emerging role of cancer stem cells in the biology and treatment of ovarian cancer: basic knowledge and therapeutic possibilities for an innovative approach

  2013cites this paper
• MicroRNA-128 coordinately targets Polycomb Repressor Complexes in glioma stem cells.

  2013cites this paper
• Bmi-1 Promotes Glioma Angiogenesis by Activating NF-κB Signaling

  2013cites this paper
• Phosphorylation of Nanog is Essential to Regulate Bmi1 and Promote Tumorigenesis

  2013cites this paper
• MicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasis.

  2013cites this paper
• The Bmi-1/NF-κB/VEGF story: another hint for proteasome involvement in glioma angiogenesis?

  2013cites this paper
• MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1.

  2013cites this paper
• Downregulation of miR-452 Promotes Stem-Like Traits and Tumorigenicity of Gliomas

  2013cites this paper
• BMI1 expression identifies subtypes of Merkel cell carcinoma

  2012cites this paper
• Antitumor effect of dehydroxymethylepoxyquinomicin, a small molecule inhibitor of nuclear factor-κB, on glioblastoma.

  2012cites this paper
• MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1

  2012cites this paper
• Bmi-1 Promotes the Chemoresistance, Invasion and Tumorigenesis of Pancreatic Cancer Cells

  2012cites this paper
• Linkage between Twist1 and Bmi1: Molecular mechanism of cancer metastasis/stemness and clinical implications

  2012cites this paper
• Clinical significance of SOX9 in human non-small cell lung cancer progression and overall patient survival

  2012cites this paper
• Bmi-1 promotes the aggressiveness of glioma via activating the NF-kappaB/MMP-9 signaling pathway

  2012cites this paper
• Role of BMI1, a Stem Cell Factor, in Cancer Recurrence and Chemoresistance: Preclinical and Clinical Evidences

  2012cites this paper
• Resistance to apoptosis‐inducing stimuli in CD44+ head and neck squamous cell carcinoma cells

  2012cites this paper
• Direct activation of Bmi1 by Twist1: implications in cancer stemness, epithelial-mesenchymal transition, and clinical significance.

  2011cites this paper
• Epithelial-mesenchymal transition and cancer stemness: the Twist1-Bmi1 connection.

  2011cites this paper
• Sulforaphane Suppresses Polycomb Group Protein Level via a Proteasome-Dependent Mechanism in Skin Cancer Cells

  2011cites this paper
• Enhancing Chemotherapy Response with Bmi-1 Silencing in Ovarian Cancer

  2011cites this paper
• Sphingosine Kinase 1 Regulates the Akt/FOXO3a/Bim Pathway and Contributes to Apoptosis Resistance in Glioma Cells

  2011cites this paper
• Emerging roles for the non-canonical IKKs in cancer

  2011cites this paper
• Influence of Caloric Restriction on Constitutive Expression of NF-κB in an Experimental Mouse Astrocytoma

  2011cites this paper
• Direct Activation of Bmi 1 by Twist 1 : Implications in Cancer Stemness , Epithelial-Mesenchymal Transition , and Clinical Significance

  2011cites this paper
• Bmi‐1 is related to proliferation, survival and poor prognosis in pancreatic cancer

  2010cites this paper
• Bmi1 is essential in Twist1-induced epithelial–mesenchymal transition

  2010cites this paper
• Establishment of Prognostic Models for Astrocytic and Oligodendroglial Brain Tumors with Standardized Quantification of Marker Gene Expression and Clinical Variables

  2010cites this paper
• The Role of Polycomb Group Gene BMI-1 in the Development of Prostate Cancer

  2009cites this paper